Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Finetti

Showing results (101-110 of 180) with videos related to

Pageof 18
Sort By:
Cancer Letters|February 17, 2019
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2Romain Lévêque, Cyril Corbet, Léo Aubert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expressionMarion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
Acta Neuropathologica Communications|November 21, 2013
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling studyCorinne Bouvier, François Bertucci, Philippe Métellus, et al.
BMC Cancer|October 17, 2006
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancersAnne Letessier, Fabrice Sircoulomb, Christophe Ginestier, et al.
Plos One|August 22, 2014
Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparibMarine Gilabert, Simon Launay, Christophe Ginestier, et al.
Cancer Research|December 20, 2007
Integrated profiling of basal and luminal breast cancersJosé Adélaïde, Pascal Finetti, Ismahane Bekhouche, et al.
Cancer Research|August 14, 2014
EFA6B antagonizes breast cancerJoséphine Zangari, Mariagrazia Partisani, François Bertucci, et al.
Molecular Oncology|March 15, 2015
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancerJennifer L Allensworth, Myron K Evans, François Bertucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2026
Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic SarcomaMariella Spalato Ceruso, Jean-Philippe Guégan, Aurelien Bourdon, et al.
Genes & Development|April 14, 2017
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyRuth Rodriguez-Barrueco, Erin A Nekritz, François Bertucci, et al.
Pageof 18

Showing results (101-110 of 180) with videos related to

Sort By:
Pageof 18
Cancer Letters|February 17, 2019
ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2Romain Lévêque, Cyril Corbet, Léo Aubert, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2013
The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expressionMarion A Salvador, Julien Wicinski, Olivier Cabaud, et al.
Acta Neuropathologica Communications|November 21, 2013
ALDH1 is an immunohistochemical diagnostic marker for solitary fibrous tumours and haemangiopericytomas of the meninges emerging from gene profiling studyCorinne Bouvier, François Bertucci, Philippe Métellus, et al.
BMC Cancer|October 17, 2006
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancersAnne Letessier, Fabrice Sircoulomb, Christophe Ginestier, et al.
Plos One|August 22, 2014
Poly(ADP-ribose) polymerase 1 (PARP1) overexpression in human breast cancer stem cells and resistance to olaparibMarine Gilabert, Simon Launay, Christophe Ginestier, et al.
Cancer Research|December 20, 2007
Integrated profiling of basal and luminal breast cancersJosé Adélaïde, Pascal Finetti, Ismahane Bekhouche, et al.
Cancer Research|August 14, 2014
EFA6B antagonizes breast cancerJoséphine Zangari, Mariagrazia Partisani, François Bertucci, et al.
Molecular Oncology|March 15, 2015
Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancerJennifer L Allensworth, Myron K Evans, François Bertucci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2026
Adenosine A2B Receptor Promotes Tumor Progression and Metastases in Undifferentiated Pleomorphic SarcomaMariella Spalato Ceruso, Jean-Philippe Guégan, Aurelien Bourdon, et al.
Genes & Development|April 14, 2017
miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapyRuth Rodriguez-Barrueco, Erin A Nekritz, François Bertucci, et al.
Pageof 18